Characterisation of a multimeric protein complex associated with ERp57 within the nucleus in paclitaxel-sensitive and -resistant epithelial ovarian cancer cells: The involvement of specific conformational states of β-actin

International Journal of Oncology

Volumn 37, Issue 2, 2010, Pages 445-454

  Cicchillitti, Lucia ^a   Della Corte, Anna ^a   Di Michele, Michela ^a   Donati, Maria Benedetta ^a   Rotilio, Domenico ^a   Scambia, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Chemoresistance; ERp57; Mass spectrometry; Ovarian cancer; Paclitaxel

Indexed keywords

AURORA C KINASE; BETA ACTIN; NUCLEOLIN; NUCLEOPHOSMIN; PACLITAXEL; PROTEIN; PROTEIN ERP57; UNCLASSIFIED DRUG; VIMENTIN; ACTIN; ANTINEOPLASTIC AGENT; MULTIPROTEIN COMPLEX; PDIA3 PROTEIN, HUMAN; PROTEIN DISULFIDE ISOMERASE;

ARTICLE; CELL DIVISION; CHROMOSOME SEGREGATION; GENE EXPRESSION; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; CELL NUCLEUS; CHEMISTRY; DRUG EFFECT; DRUG RESISTANCE; FEMALE; ISOLATION AND PURIFICATION; METABOLISM; NEOPLASM; OVARY TUMOR; PATHOLOGY; PHYSIOLOGY; PROTEIN MULTIMERIZATION; STRUCTURE ACTIVITY RELATION; TUMOR CELL LINE;

ACTINS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL NUCLEUS; CHROMOSOME SEGREGATION; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MULTIPROTEIN COMPLEXES; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PACLITAXEL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DISULFIDE-ISOMERASES; PROTEIN MULTIMERIZATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77954157573     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-0000693     Document Type: Article

References (71)

1. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
2. Fojo T and Menefee M: Mechanisms of multidrug resistance: the potential role of microtubule-stabilizing agents. Ann Oncol 18 (Suppl. 5): V3-V8, 2007.
3. Cicchillitti L, Di Michele M, Urbani A, Ferlini C, Donati MB, Scambia G and Rotilio D: Comparative proteomic analysis of paclitaxel sensitive A2780 epithelial ovarian cancer cell line and its resistant counterpart A2780TC1 by 2D-DIGE: the role of ERp57. J Proteome Res 8: 1902-1912, 2009.
4. Di Michele M, Della Corte A, Cicchillitti L, Del Boccio P, Urbani A, Ferlini C, Scambia G, Donati MB and Rotilio D: A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines. Biochim Biophys Acta 1794: 225-236, 2009.
5. Bernardini M, Lee CH, Beheshti B, Prasad M, Albert M, Marrano P, Begley H, Shaw P, Covens A, Murphy J, Rosen B, Minkin S, Squire JA and Macgregor PF: High-resolution mapping of genomic imbalance and identification of gene expression profiles associated with differential chemotherapy response in serous epithelial ovarian cancer. Neoplasia 7: 603-613, 2005.
6. Otsu M, Urade R, Kito M, Omura F and Kikuchi M: A possible role of ER-60 protease in the degradation of misfolded proteins in the endoplasmic reticulum. J Biol Chem 270: 14958-14961, 1995.
7. Murthy MS and Pande SV: A stress-regulated protein, GRP58, a member of thioredoxin superfamily, is a carnitine palmitoyl-transferase isoenzyme. Biochem J 304: 31-34, 1994.
8. Srivastava M and Pollard HB: Molecular dissection of nucleolin's role in growth and cell proliferation: new insights. FASEB J 13: 1911-1922, 1999.
9. Hirano N, Shibasaki F, Sakai R, Tanaka T, Nishida J, Yazaki Y, Takenawa T and Hirai H: Molecular cloning of the human glucose-regulated protein ERp57/GRP58, a thiol-dependent reductase. Identification of its secretory form and inducible expression by the oncogenic transformation. Eur J Biochem 234: 336-342, 1995.
10. Freedman RB, Hirst TR and Tuite MF: Protein disulphide isomerase: building bridges in protein folding. Trends Biochem Sci 19: 331-336, 1994. (Pubitemid 24259985)
11. Ndubuisi MI, Guo GG, Fried VA, Etlinger JD and Sehgal PB: Cellular physiology of STAT3: Where's the cytoplasmic monomer? J Biol Chem 274: 25499-25509, 1999.
12. Wyse B, Ali N and Ellison DH: Interaction with grp58 increases activity of the thiazide-sensitive Na-Cl cotransporter. Am J Physiol Renal Physiol 282: F424-F430, 2002. (Pubitemid 34654530)
13. Krynetski EY, Krynetskaia NF, Bianchi ME and Evans WE: A nuclear protein complex containing high mobility group proteins B1 and B2, heat shock cognate protein 70, ERp60, and glyceraldehyde-3-phosphate dehydrogenase is involved in the cytotoxic response to DNA modified by incorporation of anticancer nucleoside analogues. Cancer Res 63: 100-106, 2003.
14. Ferrandina G, Zannoni GF, Martinelli E, Paglia A, Gallotta V, Mozzetti S, Scambia G and Ferlini C: Class III beta-tubulin overexpression is a marker of poor clinical outcome in advanced ovarian cancer patients. Clin Cancer Res 12: 2774-2779, 2006. (Pubitemid 43752116)
15. Cochrane DR, Spoelstra NS, Howe EN, Nordeen SK and Richer JK: MicroRNA-200c mitigates invasiveness and restores sensitivity to microtubule-targeting chemotherapeutic agents. Mol Cancer Ther (In press).
16. Chen H, Bernstein BW and Bamburg JR: Regulating actin-filament dynamics in vivo. Trends Biochem Sci 25: 19-23, 2000.
17. Carlier MF, Le Clainche C, Wiesner S and Pantaloni D: Actin-based motility: from molecules to movement. Bioessays 25: 336-345, 2003.
18. Sotiropoulos A, Gineitis D, Copeland J and Treisman R: Signal-regulated activation of serum response factor is mediated by changes in actin dynamics. Cell 98: 159-169, 1999. (Pubitemid 29344904)
19. Grummt I: Actin and myosin as transcription factors. Curr Opin Genet Dev 16: 191-196, 2006.
20. Lane NJ: Intranuclear fibrillar bodies in actinomycin D-treated oocytes. J Cell Biol 40: 286-291, 1969.
21. Olave IA, Reck-Peterson SL and Crabtree GR: Nuclear actin and actin-related proteins in chromatin remodeling. Annu Rev Biochem 71: 755-781, 2002. (Pubitemid 34800234)
22. De Lanerolle P, Johnson T and Hofmann WA: Actin and myosin I in the nucleus: what next? Nat Struct Mol Biol 12: 742-746, 2005.
23. Pederson T and Aebi U: Nuclear actin extends, with no contraction in sight. Mol Biol Cell 16: 5055-5060, 2005. (Pubitemid 41566818)
24. Percipalle P and Visa N: Molecular functions of nuclear actin in transcription. J Cell Biol 172: 967-971, 2006.
25. Sjolinder M, Bjork P, Soderberg E, Sabri N, Farrants AK and Visa N: The growing pre-mRNA recruits actin and chromatin-modifying factors to transcriptionally active genes. Genes Dev 19: 1871-1884, 2005.
26. Ferlini C, Raspaglio G, Mozzetti S, Distefano M, Filippetti F, Martinelli E, Ferrandina G, Gallo D, Ranelletti FO and Scambia G: Bcl-2 down-regulation is a novel mechanism of paclitaxel resistance. Mol Pharmacol 64: 51-58, 2003.
27. Klappa P, Stromer T, Zimmermann R, Ruddock LW and Freedman RB: A pancreas-specific glycosylated protein disulphide-isomerase binds to misfolded proteins and peptides with an interaction inhibited by oestrogens. Eur J Biochem 254: 63-69, 1998.
28. Kita K, Okumura N, Takao T, Watanabe M, Matsubara T, Nishimura O and Nagai K: Evidence for phosphorylation of rat liver glucose-regulated protein 58, GRP58/ERp57/ER-60, induced by fasting and leptin. FEBS Lett 580: 199-205, 2006.
29. Tokutomi Y, Arak, N, Kataoka K, Yamamoto E and Kim-Mitsuyama S: Oxidation of Prx2 and phosphorylation of GRP58 by angiotensin II in human coronary smooth muscle cells identified by 2D-DIGE analysis. Biochem Biophys Res Commun 364: 822-830, 2007.
30. Storck S, Shukla M, Dimitrov S and Bouvet P: Functions of the histone chaperone nucleolin in diseases. Subcell Biochem 41: 125-144, 2007.
31. Yang C, Maiguel DA and Carrier F: Identification of nucleolin and nucleophosmin as genotoxic stress-responsive RNA-binding proteins. Nucleic Acids Res 30: 2251-2260, 2002. (Pubitemid 34567946)
32. Kimura M, Matsuda Y, Yoshioka T and Okano Y: Cell cycle-dependent expression and centrosome localization of a third human aurora/Ipl1-related protein kinase, AIK3. J Biol Chem 274: 7334-7340, 1999. (Pubitemid 129505026)
33. Li X, Sakashita G, Matsuzaki H, Sugimoto K, Kimura K Hanaoka F, Taniguchi H, Furukawa K and Urano, T: Direct association with inner centromere protein (INCENP) activates the novel chromosomal passenger protein, Aurora-C. J Biol Chem 279: 47201-47211, 2004. (Pubitemid 39518377)
34. Vader G and Lens SM: The Aurora kinase family in cell division and cancer. Biochim Biophys Acta 1786: 60-72, 2008.
35. Tao X, Chon HS, Fu S, Kavanagh JJ and Hu W: Update on aurora kinase inhibitors in gynecologic malignancies. Recent Pat Anticancer Drug Discov 3: 162-177, 2008.
36. Macarulla T, Ramos FJ and Tabernero J: Aurora kinase family: a new target for anticancer drug. Recent Pat Anticancer Drug Discov 3: 114-122, 2008.
37. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR and Sen S: Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 20: 189-193, 1998. (Pubitemid 28455454)
38. Izawa I and Inagaki M: Regulatory mechanisms and functions of intermediate filaments: a study using site- and phosphorylation state-specific antibodies. Cancer Sci 97: 167-174, 2006.
39. Jonsson AP, Aissouni Y, Palmberg C, Percipalle P, Nordling E, Daneholt B, Jornvall H and Bergman T: Recovery of gel-separated proteins for in-solution digestion and mass spectrometry. Anal Chem 73: 5370-5377, 2001. (Pubitemid 33108544)
40. Kwon M, Godinho SA, Chandhok NS, Ganem NJ, Azioune A, Thery M and Pellman D: Mechanisms to suppress multipolar divisions in cancer cells with extra centrosomes. Genes Dev 22: 2189-2203, 2008.
41. Xu FL and Saunders WS: Actin and microtubules: working together to control spindle polarity. Cancer Cell 14: 197-199, 2008.
42. Lassing I, Schmitzberger F, Bjornstedt M, Holmgren A, Nordlund P, Schutt CE and Lindberg U: Molecular and structural basis for redox regulation of beta-actin. J Mol Biol 370: 331-348, 2007. (Pubitemid 46829216)
43. Schoenenberger CA, Buchmeier S, Boerries M, Sutterlin R, Aebi U and Jockusch BM: Conformation-specific antibodies reveal distinct actin structures in the nucleus and the cytoplasm. J Struct Biol 152: 157-168, 2005. (Pubitemid 41785513)
44. Gonsior SM, Platz S, Buchmeier S, Scheer U, Jockusch BM and Hinssen H: Conformational difference between nuclear and cytoplasmic actin as detected by a monoclonal antibody. J Cell Sci 112: 797-809, 1999. (Pubitemid 29179313)
45. Frenkel Z, Shenkman M, Kondratyev M and Lederkremer GZ: Separate roles and different routing of calnexin and ERp57 in endoplasmic reticulum quality control revealed by interactions with asialoglycoprotein receptor chains. Mol Biol Cell 15: 2133-2142, 2004. (Pubitemid 38580633)
46. Molinari M and Helenius A: Glycoproteins form mixed disulphides with oxidoreductases during folding in living cells. Nature 402: 90-93, 1999. (Pubitemid 29533521)
47. Ni M and Lee AS: ER chaperones in mammalian development and human diseases. FEBS Lett 581: 3641-3651, 2007. (Pubitemid 47082516)
48. Cicchillitti L, Penci R, Di Michele M, Filippetti F, Rotilio D, Donati MB, Scambia G and Ferlini C: Proteomic characterization of cytoskeletal and mitochondrial class III beta-tubulin. Mol Cancer Ther 7: 2070-2079, 2008.
49. Coppari S, Altieri F, Ferraro A, Chichiarelli S, Eufemi M and Turano C: Nuclear localization and DNA interaction of protein disulfide isomerase ERp57 in mammalian cells. J Cell Biochem 85: 325-333, 2002. (Pubitemid 34274900)
50. Grillo C, D'Ambrosio C, Scaloni A, Maceroni M, Merluzzi S, Turano C and Altieri F: Cooperative activity of Ref-1/APE and ERp57 in reductive activation of transcription factors. Free Radic Biol Med 41: 1113-1123, 2006. (Pubitemid 44331573)
51. Celli CM and Jaiswal AK: Role of GRP58 in mitomycin C-induced DNA cross-linking. Cancer Res 63: 6016-6025, 2003.
52. Adikesavan AK, Unni E and Jaiswal AK: Overlapping signal sequences control nuclear localization and endoplasmic reticulum retention of GRP58. Biochem Biophys Res Commun 377: 407-412, 2008.
53. Amin MA, Matsunaga S, Uchiyama S and Fukui K: Nucleophosmin is required for chromosome congression, proper mitotic spindle formation, and kinetochore-microtubule attachment in HeLa cells. FEBS Lett 582: 3839-3844, 2008.
54. Li J, Zhang X, Sejas DP, Bagby GC and Pang Q: Hypoxia-induced nucleophosmin protects cell death through inhibition of p53. J Biol Chem 279: 41275-41279, 2004. (Pubitemid 39313565)
55. Kollareddy M, Dzubak P, Zheleva D and Hajduch M: Aurora kinases: structure, functions and their association with cancer. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 152: 27-33, 2008.
56. VanderPorten EC, Taverna P, Hogan JN, Ballinger MD, Flanagan WM and Fucini RV: The Aurora kinase inhibitor SNS-314 shows broad therapeutic potential with chemo+- therapeutics and synergy with microtubule-targeted agents in a colon carcinoma model. Mol Cancer Ther 8: 930-939, 2009.
57. Curry J, Angove H, Fazal L, Lyons J, Reule M, Thompson N and Wallis N: Aurora B kinase inhibition in mitosis: strategies for optimising the use of aurora kinase inhibitors such as AT9283. Cell Cycle 8: 1921-1929, 2009.
58. Scharer CD, Laycock N, Osunkoya AO, Logani S, McDonald JF, Benigno BB and Moreno CS: Aurora kinase inhibitors synergize with paclitaxel to induce apoptosis in ovarian cancer cells. J Transl Med 6: 79, 2008.
59. Fukui K and Uchiyama S: Chromosome protein framework from proteome analysis of isolated human metaphase chromosomes. Chem Rec 7: 230-237, 2007.
60. Slawson C, Lakshmanan T, Knapp S and Hart GW: A mitotic GlcNAcylation/phosphorylation signaling complex alters the posttranslational state of the cytoskeletal protein vimentin. Mol Biol Cell 19: 4130-4140, 2008.
61. Bengtsson S, Krogh M, Szigyarto CA, Uhlen M, Schedvins K, Silfversward C, Linder S, Auer G, Alaiya A and James P: Large-scale proteomics analysis of human ovarian cancer for biomarkers. J Proteome Res 6: 1440-1450, 2007. (Pubitemid 46724042)
62. Chen JG and Horwitz SB: Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs. Cancer Res 62: 1935-1938, 2002.
63. Chen JG, Yang CP, Cammer M and Horwitz SB: Gene expression and mitotic exit induced by microtubule-stabilizing drugs. Cancer Res 63: 7891-7899, 2003. (Pubitemid 37466724)
64. Pederson T: As functional nuclear actin comes into view, is it globular, filamentous, or both? J Cell Biol 180: 1061-1064, 2008.
65. Schleicher M and Jockusch BM: Actin: its cumbersome pilgrimage through cellular compartments. Histochem Cell Biol 129: 695-704, 2008.
66. Dos Remedios CG, Chhabra D, Kekic M, Dedova IV, Tsubakihara M, Berry DA and Nosworthy NJ: Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol Rev 83: 433-473, 2003. (Pubitemid 36378678)
67. Wang J, Tekle E, Oubrahim H, Mieyal JJ, Stadtman ER and Chock PB: Stable and controllable RNA interference: investigating the physiological function of glutathionylated actin. Proc Natl Acad Sci USA 100: 5103-5106, 2003.
68. Aslan M, Ryan TM, Townes TM, Coward L, Kirk MC, Barnes S, Alexander CB, Rosenfeld SS and Freeman BA: Nitric oxidedependent generation of reactive species in sickle cell disease. Actin tyrosine induces defective cytoskeletal polymerization. J Biol Chem 278: 4194-4204, 2003.
69. Thom SR, Bhopale VM, Mancini DJ and Milovanova TN: Actin S-nitrosylation inhibits neutrophil beta2 integrin function. J Biol Chem 283: 10822-10834, 2008.
70. Karakozova M, Kozak M, Wong CC, Bailey AO, Yates JR III, Mogilner A, Zebroski H and Kashina A: Arginylation of beta-actin regulates actin cytoskeleton and cell motility. Science 313: 192-196, 2006.
71. Hofmann WA, Arduini A, Nicol SM, Camacho CJ, Lessard JL, Fuller-Pace FV and De Lanerolle P: SUMOylation of nuclear actin. J Cell Biol 186: 193-200, 2009.